Country: United States
Language: English
Source: NLM (National Library of Medicine)
Hydrochlorothiazide (UNII: 0J48LPH2TH) (Hydrochlorothiazide - UNII:0J48LPH2TH)
Oxford Pharmaceuticals, LLC
ORAL
PRESCRIPTION DRUG
CONTRAINDICATIONS Anuria. Hypersensitivity to this product or to other sulfonamide-derived drugs
HOW SUPPLIED Hydrochlorothiazide Tablets, USP are supplied as follows: 25 mg - Peach, Round scored tablets, upper debossed with "361" above bisect and lower debossed "O". Available in bottles of: 100, NDC 69584-361-10 1000, NDC 69584-361-90 5000, NDC 69584-361-95 50 mg - Peach, Round scored tablets, upper debossed with "362" above bisect and lower debossed "O". Available in bottles of: 100, NDC 69584-362-10 1000, NDC 69584-362-90. Store at: 20-25°C (68-77°F). [See USP Controlled Room Temperature]. Dispense in a well-closed container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured by: Oxford Pharmaceuticals, LLC Birmingham, Alabama 35211 8200020 Revised: 08/2020 R00
Abbreviated New Drug Application
HYDROCHLOROTHIAZIDE- HYDROCHLOROTHIAZIDE TABLET OXFORD PHARMACEUTICALS, LLC ---------- HYDROCHLOROTHIAZIDE TABLETS, USP RX ONLY DESCRIPTION Hydrochlorothiazide is a diuretic and antihypertensive. It is the 3,4-dihydro derivative of chlorothiazide. Its chemical name is 6-chloro-3,4-dihyrdo-2_H_-1,2,4-benzothiadiazine-7- sulfonamide1,1-dioxide, and its structural formula is Hydrochlorothiazide is a white, or practically white, crystalline powder, which is slightly soluble in water, but freely soluble in sodium hydroxide solution. Each tablet, for oral administration, contains 25 mg or 50 mg hydrochlorothiazide. In addition. each tablet contains the following inactive ingredients: Anhydrous Lactose, Pregelatinized Starch from Corn, Magnesium Stearate, Microcrystalline Cellulose, and FD&C Yellow #6. CLINICAL PHARMACOLOGY The mechanism of the antihypertensive effect of thiazides is unknown. Hydrochlorothiazide does not usually affect normal blood pressure. Hydrochlorothiazide affects the distal renal tubular mechanism of electrolyte reabsorption. At maximal therapeutic dosage all thiazides are approximately equal in their diuretic efficacy. Hydrochlorothiazide increases excretion of sodium and chloride in approximately equivalent amounts. Natriuresis may be accompanied by some loss of potassium and bicarbonate. After oral use diuresis begins within 2 hours. peaks in about 4 hours and lasts about 6 to 12 hours. PHARMACOKINETICS AND METABOLISM Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney. When plasma levels have been followed for at least 24 hours, the plasma half- life has been observed to vary between 5.6 and 14.8 hours. At least 61 percent of the oral dose is eliminated unchanged within 24 hours. Hydrochlorothiazide crosses the placental but not the blood-brain barrier and is excreted in breast milk. INDICATIONS AND USAGE Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estroge Read the complete document